J Korean Ophthalmol Soc > Volume 51(10); 2010 > Article
Journal of the Korean Ophthalmological Society 2010;51(10):1319-1326.
DOI: https://doi.org/10.3341/jkos.2010.51.10.1319    Published online October 15, 2010.
Effect of Topical 0.05% Cyclosporine A in Dry Eye Associated With Thyroid Ophthalmopathy.
Won Choi, Yeoung Geol Park, Jae Kap Cho, Kyung Chul Yoon
1Department of Ophthalmology, Chonnam National University Hospital, Medical School, Gwangju, Korea. kcyoon@chonnam.ac.kr
2Department of Ophthalmology, Seonam University College of Medicine, Namwon, Korea.
건성안을 동반한 갑상샘안병증에서 0.05% 사이클로스포린 A 점안액 사용 후 눈물막과 안구표면의 변화
최원1ㆍ박영걸1ㆍ조재갑2ㆍ윤경철1
Department of Ophthalmology, Chonnam National University Hospital, Medical School1, Gwangju, Korea Department of Ophthalmology, Seonam University College of Medicine2, Namwon, Korea
Abstract
PURPOSE
The present study was performed to evaluate the changes in tear film and ocular surface parameters after using sodium hyaluronate (SH) 0.1% alone or in combination with cyclosporine A (CsA) 0.05% in patients with thyroid-associated ophthalmopathy accompanied by dry eye. METHODS: A total of 72 eyes from 36 patients were divided into two groups; 36 eyes of 18 patients were treated with 0.1% SH alone (group 1), and 36 eyes of 18 patients were treated with SH 0.1% and CsA 0.05% (group 2). Tear break-up time (BUT), basal tear secretion test (BST), tear clearance rate (TCR), fluorescein staining (FS) and corneal sensitivity test (CST) were evaluated at pre-treatment and one, three and six months post-treatment. Conjunctival impression cytology was performed and tear CXCL11 (Chemokine (C-X-C motif) ligand) levels were measured pre-treatment and three months post-treatment. RESULTS: BUT, BST, TCR, KEP and CST were significantly improved at six months in group 1 (p < 0.05) and at three months in group 2 (p < 0.05). The degree of conjunctival squamous cell metaplasia, goblet cell density and tear CXCL11 levels were significantly changed at three months in group 2 (p < 0.05). However, there were no significant changes in group 1 after 3 months. CONCLUSIONS: Combined use of topical 0.1% SH and 0.05% CsA can result in early improvement in tear films and ocular surface parameters in patients with thyroid-associated ophthalmopathy accompanied by dry eye.
Key Words: Cyclosporine;Dry eye syndrome;Sodium hyaluronate;Thyroid associated ophthalmopathy


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next